Amy Blase

3.1k total citations
35 papers, 2.1k citations indexed

About

Amy Blase is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Amy Blase has authored 35 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Amy Blase's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (18 papers) and Obstructive Sleep Apnea Research (10 papers). Amy Blase is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (18 papers) and Obstructive Sleep Apnea Research (10 papers). Amy Blase collaborates with scholars based in United States, Germany and Canada. Amy Blase's co-authors include Harry G. Rittenhouse, Jack Groskopf, Sheila M. J. Aubin, Ina L. Deras, Leonard S. Marks, Yves Fradet, William J. Ellis, Seongjoon Koo, John Day and Alan W. Partin and has published in prestigious journals such as Journal of the American College of Cardiology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Amy Blase

34 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Blase United States 16 1.7k 644 580 262 257 35 2.1k
Robert E. Parson United States 7 947 0.6× 111 0.2× 301 0.5× 183 0.7× 261 1.0× 8 1.3k
Jacques Planas Spain 22 1.2k 0.7× 272 0.4× 330 0.6× 165 0.6× 222 0.9× 137 1.6k
Yukie Takimoto Japan 12 465 0.3× 131 0.2× 235 0.4× 92 0.4× 92 0.4× 29 785
Per-Anders Abrahamsson Sweden 14 642 0.4× 81 0.1× 160 0.3× 92 0.4× 170 0.7× 19 841
Noriyoshi Miura Japan 18 343 0.2× 119 0.2× 212 0.4× 270 1.0× 43 0.2× 70 757
M Bolla France 9 435 0.3× 87 0.1× 81 0.1× 153 0.6× 48 0.2× 26 765
Takehiro Sejima Japan 17 367 0.2× 176 0.3× 246 0.4× 258 1.0× 123 0.5× 71 834
S. Ozono Japan 15 312 0.2× 95 0.1× 294 0.5× 150 0.6× 47 0.2× 74 698
Valérie Nadeau Canada 16 554 0.3× 202 0.3× 463 0.8× 122 0.5× 20 0.1× 28 976
Suguru Shirotake Japan 20 431 0.3× 146 0.2× 209 0.4× 479 1.8× 26 0.1× 89 1.1k

Countries citing papers authored by Amy Blase

Since Specialization
Citations

This map shows the geographic impact of Amy Blase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Blase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Blase more than expected).

Fields of papers citing papers by Amy Blase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Blase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Blase. The network helps show where Amy Blase may publish in the future.

Co-authorship network of co-authors of Amy Blase

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Blase. A scholar is included among the top collaborators of Amy Blase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Blase. Amy Blase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blase, Amy, et al.. (2025). Phased blood-brain barrier disruption in ischaemic stroke: implications for therapy?. Fluids and Barriers of the CNS. 22(1). 90–90.
2.
Kumar, Shefali, Cynthia M. Dorsey, Kimberly Caswell, et al.. (2023). Pilot study of positive airway pressure usage, patient journey and program engagement for users of a digital obstructive sleep apnea program. Frontiers in Digital Health. 5. 1043578–1043578. 1 indexed citations
3.
Bhattacharjee, Rakesh, et al.. (2021). The accuracy of a portable sleep monitor to diagnose obstructive sleep apnea in adolescent patients. Journal of Clinical Sleep Medicine. 17(7). 1379–1387. 14 indexed citations
4.
Kumar, Shefali, et al.. (2021). Assessment of Patient Journey Metrics for Users of a Digital Obstructive Sleep Apnea Program: Single-Arm Feasibility Pilot Study. JMIR Formative Research. 6(1). e31698–e31698. 3 indexed citations
5.
Sawyer, Amy M., Douglas M. Wallace, Luis F. Buenaver, et al.. (2020). Where to Next for Optimizing Adherence in Large-Scale Trials of Continuous Positive Airway Pressure?. Sleep Medicine Clinics. 16(1). 125–144. 4 indexed citations
6.
Berry, Richard B., et al.. (2019). 0463 Validation of a Home Sleep Apnea Testing Device for the Diagnosis of Sleep Disordered Breathing based on AASM 2012 guidelines. SLEEP. 42(Supplement_1). A186–A186. 8 indexed citations
7.
Daubert, Melissa A., David J. Whellan, Holger Woehrle, et al.. (2018). Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial. American Heart Journal. 201. 40–48. 21 indexed citations
8.
Piccini, Jonathan P., Sean D. Pokorney, Kevin J. Anstrom, et al.. (2018). Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea. Heart Rhythm. 16(1). 91–97. 15 indexed citations
9.
O’Connor, Christopher M., David J. Whellan, Mona Fiuzat, et al.. (2017). Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure. Journal of the American College of Cardiology. 69(12). 1577–1587. 97 indexed citations
10.
11.
Aubin, Sheila M. J., Jennifer Reid, Mark Sarno, et al.. (2011). Prostate Cancer Gene 3 Score Predicts Prostate Biopsy Outcome in Men Receiving Dutasteride for Prevention of Prostate Cancer: Results From the REDUCE Trial. Urology. 78(2). 380–385. 16 indexed citations
12.
Aubin, Sheila M. J., Jennifer Reid, Mark Sarno, et al.. (2010). PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial. The Journal of Urology. 184(5). 1947–1952. 102 indexed citations
13.
Nakanishi, Hiroyuki, Jack Groskopf, Herbert A. Fritsche, et al.. (2008). PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance. The Journal of Urology. 179(5). 1804–1810. 217 indexed citations
14.
Deras, Ina L., Sheila M. J. Aubin, Amy Blase, et al.. (2008). PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome. The Journal of Urology. 179(4). 1587–1592. 343 indexed citations
15.
Marks, Leonard S., Yves Fradet, Ina L. Deras, et al.. (2007). PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy. Urology. 69(3). 532–535. 335 indexed citations
16.
Sokoll, Lori J., William Ellis, Paul H. Lange, et al.. (2007). A multicenter evaluation of the PCA3 molecular urine test: Pre-analytical effects, analytical performance, and diagnostic accuracy. Clinica Chimica Acta. 389(1-2). 1–6. 87 indexed citations
17.
Partin, Alan W., Leslie A. Mangold, Robin Gurganus, et al.. (2007). 1623: Biological Variation of PCA3 Score in Men Previously Diagnosed with Prostate Cancer. The Journal of Urology. 177(4S). 538–538. 3 indexed citations
18.
Marks, Leonard S., Sheila M. J. Aubin, Ina L. Deras, et al.. (2006). 540: Specificity of the Aptima® PCA3 Assay for Prostate Cancer. The Journal of Urology. 175(4S). 175–176. 1 indexed citations
19.
Groskopf, Jack, Ina L. Deras, Amy Blase, et al.. (2006). SPECIFICITY OF THE APTIMA® PCA3 ASSAY FOR PROSTATE CANCER. European Urology Supplements. 5(2). 240–240. 1 indexed citations
20.
Fradet, Yves, Jack Groskopf, Ina L. Deras, et al.. (2006). APTIMA® PCA3 MOLECULAR URINE TEST: DEVELOPMENT OF A METHOD TO AID IN THE DIAGNOSIS OF PROSTATE CANCER. European Urology Supplements. 5(2). 275–275. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Parson Breakdown of academic impact, for papers by Jacques Planas Breakdown of academic impact, for papers by Yukie Takimoto Breakdown of academic impact, for papers by Per-Anders Abrahamsson Breakdown of academic impact, for papers by Noriyoshi Miura Breakdown of academic impact, for papers by M Bolla Breakdown of academic impact, for papers by Takehiro Sejima Breakdown of academic impact, for papers by S. Ozono Breakdown of academic impact, for papers by Valérie Nadeau Breakdown of academic impact, for papers by Suguru Shirotake
Rankless by CCL
2026